See more markers, in fewer cells, in less time
A single-cell platform that measures up to 25 epigenetic
marks in one assay – no sequencing required.
Developed at CBMSO, CSIC–UAM
Validated with academic and pharmaceutical partners.
Up to 25
epigenetic marks
in one assay
Single-cell
resolution across
every mark
Days, not weeks
from sample to
actionable insight
No sequencing
lower cost and
complexity
About Spectral Discovery
Your sample is limited.
Your ambition shouldn’t be.
The problem
Current tools ask you to choose what to sacrifice.
Measuring several epigenetic marks in the same individual cell has always meant compromising on sample, cost, time or resolution.
Our solution
One assay. Many marks. Single-cell resolution.
Spectral flow cytometry, a customizable antibody panel and proprietary data processing reveal the wider epigenetic state of each cell.
Explore Spectral Discovery
Start with the question that matters to you.
From the limits of current methods to the practical difference our platform makes.
The problem
Why today’s epigenetic tools still force difficult compromises.
Our solution
Hoy one multiplexed assay creates a richer view of every cell.
How it works
A clear path form sample preparation to interpretable results.
Why it’s different
A transparent comparisonn with established approaches.
How our technology works
From sample to high-dimensional insight.
The home keeps the process simple. The dedicated technology page can add real experiments, output visualisations and scientific detail.
Prepare
Preserve precious cells in a streamlined assay.
Measure
Read a customizable panel of up to 25 marks.
Resolve
Separate responses cell by cell and population by population.
Interpret
Turn high-dimensional data into comparable profiles.
Built for real research decisions
One platform.
Different questions.
For Pharma and Biotech
See the whole picture.
Screen epigenetic drug candidates across targets, doses and time points. Detect intended and off-target effects before they emerge later in development.
– Compound screening
– Mechanism-of-action validation
– Off-target effect detection
For Academic Research
With smaller samples.
Get a multi-mark epigenetic profile from limited brain tissue, blood or biopsies without splitting material across multiple techniques.
– Target discovery
– Cell heterogeneity
– Pre-sequencing validation
What could you see with a richer view of every cell?
Tell us about your samples, targets or development question.
We’ll explore whether Spectral Discovery is the right fit.